WELL Health Technologies Future Growth
Future criteria checks 1/6
WELL Health Technologies's earnings are forecast to decline at 10.7% per annum while its annual revenue is expected to grow at 10.4% per year. EPS is expected to grow by 6.6% per annum.
Key information
-10.7%
Earnings growth rate
6.6%
EPS growth rate
| Healthcare earnings growth | 57.6% |
| Revenue growth rate | 10.4% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 16 Dec 2024 |
Recent future growth updates
Recent updates
A Piece Of The Puzzle Missing From WELL Health Technologies Corp.'s (TSE:WELL) 27% Share Price Climb
Nov 29
When Should You Buy WELL Health Technologies Corp. (TSE:WELL)?
Nov 11Is WELL Health Technologies (TSE:WELL) A Risky Investment?
Sep 09Market Participants Recognise WELL Health Technologies Corp.'s (TSE:WELL) Revenues Pushing Shares 30% Higher
Jul 05WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 60% Above Its Share Price
Jun 11WELL Health Technologies' (TSE:WELL) Earnings Are Weaker Than They Seem
May 21WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly
Mar 21Is WELL Health Technologies Corp. (TSE:WELL) Trading At A 40% Discount?
Feb 29The Price Is Right For WELL Health Technologies Corp. (TSE:WELL)
Jan 18WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly
Oct 30We Think WELL Health Technologies (TSE:WELL) Can Stay On Top Of Its Debt
Jul 17WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly
Apr 18Are Investors Undervaluing WELL Health Technologies Corp. (TSE:WELL) By 40%?
Jan 13Should You Think About Buying WELL Health Technologies Corp. (TSE:WELL) Now?
Nov 11Is WELL Health Technologies Corp. (TSE:WELL) Potentially Undervalued?
Aug 09WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 43% Above Its Share Price
May 31Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,202 | 45 | 99 | 130 | 5 |
| 12/31/2025 | 1,112 | 12 | 80 | 123 | 15 |
| 12/31/2024 | 989 | 50 | 78 | 171 | 15 |
| 9/30/2024 | 958 | 73 | 112 | 127 | N/A |
| 6/30/2024 | 910 | 147 | 67 | 89 | N/A |
| 3/31/2024 | 838 | 30 | 49 | 68 | N/A |
| 12/31/2023 | 776 | 0 | 41 | 66 | N/A |
| 9/30/2023 | 701 | -7 | 60 | 81 | N/A |
| 6/30/2023 | 643 | -4 | 61 | 76 | N/A |
| 3/31/2023 | 612 | -5 | 67 | 81 | N/A |
| 12/31/2022 | 569 | 1 | 70 | 77 | N/A |
| 9/30/2022 | 528 | -29 | 20 | 56 | N/A |
| 6/30/2022 | 482 | -37 | 5 | 49 | N/A |
| 3/31/2022 | 403 | -45 | -19 | 34 | N/A |
| 12/31/2021 | 302 | -44 | -30 | 22 | N/A |
| 9/30/2021 | 204 | -29 | -13 | 10 | N/A |
| 6/30/2021 | 117 | -21 | -10 | 2 | N/A |
| 3/31/2021 | 66 | -9 | -4 | -4 | N/A |
| 12/31/2020 | 50 | -4 | -7 | -5 | N/A |
| 9/30/2020 | 43 | -9 | -5 | -4 | N/A |
| 6/30/2020 | 39 | -10 | -4 | -3 | N/A |
| 3/31/2020 | 36 | -8 | -4 | -3 | N/A |
| 12/31/2019 | 33 | -8 | -3 | -3 | N/A |
| 12/31/2018 | 9 | -2 | -1 | -1 | N/A |
| 10/31/2018 | 6 | -2 | -1 | -1 | N/A |
| 7/31/2018 | 4 | -6 | N/A | -1 | N/A |
| 4/30/2018 | 2 | -6 | N/A | -1 | N/A |
| 1/31/2018 | 0 | -6 | N/A | -1 | N/A |
| 10/31/2017 | N/A | -1 | N/A | -1 | N/A |
| 7/31/2017 | 0 | -1 | N/A | -1 | N/A |
| 3/31/2017 | 0 | 0 | N/A | -1 | N/A |
| 12/31/2016 | 0 | 0 | N/A | 0 | N/A |
| 10/31/2016 | 0 | -1 | N/A | 0 | N/A |
| 12/31/2015 | 0 | -1 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: WELL's earnings are forecast to decline over the next 3 years (-10.7% per year).
Earnings vs Market: WELL's earnings are forecast to decline over the next 3 years (-10.7% per year).
High Growth Earnings: WELL's earnings are forecast to decline over the next 3 years.
Revenue vs Market: WELL's revenue (10.4% per year) is forecast to grow faster than the Canadian market (7.1% per year).
High Growth Revenue: WELL's revenue (10.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if WELL's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 02:03 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
WELL Health Technologies Corp. is covered by 25 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Gabriel Leung | Beacon Securities Limited |
| Douglas Taylor | Canaccord Genuity |
| Scott Fletcher | CIBC Capital Markets |